+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Blood Cell"

United Arab Emirates (UAE) Biobanking Market Overview, 2029 - Product Thumbnail Image

United Arab Emirates (UAE) Biobanking Market Overview, 2029

  • Report
  • May 2024
  • 68 Pages
  • United Arab Emirates United Arab Emirates
From
Disease Analysis: Acute Myeloid Leukemia (AML) - Product Thumbnail Image

Disease Analysis: Acute Myeloid Leukemia (AML)

  • Report
  • April 2021
  • 120 Pages
  • Global
Molecular Hematology. Edition No. 5 - Product Thumbnail Image

Molecular Hematology. Edition No. 5

  • Book
  • April 2024
  • 448 Pages
Sensors and Probes for Bioimaging. Edition No. 1 - Product Thumbnail Image

Sensors and Probes for Bioimaging. Edition No. 1

  • Book
  • August 2023
  • 368 Pages
Neonatal Haematology. A Practical Guide. Edition No. 1 - Product Thumbnail Image

Neonatal Haematology. A Practical Guide. Edition No. 1

  • Book
  • September 2022
  • 304 Pages
Nanotechnology for Microfluidics. Edition No. 1 - Product Thumbnail Image

Nanotechnology for Microfluidics. Edition No. 1

  • Book
  • February 2020
  • 448 Pages
Loading Indicator

The Blood Cell market is a subset of the biotechnology industry that focuses on the development of products and services related to the study and manipulation of blood cells. This includes the production of blood cell-based therapeutics, such as monoclonal antibodies, as well as the development of diagnostic tests and treatments for blood-related diseases. Blood cell research is also used to develop treatments for cancer, autoimmune diseases, and other conditions. The Blood Cell market is a rapidly growing sector of the biotechnology industry, with new products and services being developed to meet the needs of patients and healthcare providers. Companies in this market are focused on developing innovative technologies and treatments to improve patient outcomes and reduce healthcare costs. Some of the companies in the Blood Cell market include AbbVie, Amgen, AstraZeneca, Biogen, Celgene, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Regeneron Pharmaceuticals. Show Less Read more